Jana McConnell
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: Oak Ridge National Laboratory (2001)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Jana McConnell's research focuses on the health outcomes of extremely preterm infants, particularly concerning the use of erythropoietin and the impact of transfusions. Her work investigates the short- and long-term kidney-related outcomes in neonates of extremely low gestational age, examining the effects of erythropoietin in a multicenter, double-blind, placebo-controlled randomized clinical trial. She has also studied the association between term equivalent brain magnetic resonance imaging and 2-year outcomes in this vulnerable population, as well as the association between urinary biomarkers and chronic kidney disease in extremely low gestational age neonates. Further investigations include the relationship between iron supplementation and the risk of bronchopulmonary dysplasia. McConnell's scholarship metrics include an h-index of 5, with a total of 9 publications and 146 citations.
Metrics
- h-index: 5
- Publications: 9
- Citations: 147
Selected Publications
-
Association Between Urinary Biomarkers and CKD in Extremely Low Gestational Age Neonates (2023)
-
Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns (2022)
-
Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial (2021)
Collaboration Network
Top Collaborators
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Association Between Urinary Biomarkers and CKD in Extremely Low Gestational Age Neonates
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Association Between Urinary Biomarkers and CKD in Extremely Low Gestational Age Neonates
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
Similar Researchers
Based on overlapping research topics